Dermatitis - atopic and Nosebleed

Summary:

Nosebleed is found among people with Dermatitis - atopic, especially for people who are female, 40-49 old.

The study analyzes which people have Nosebleed with Dermatitis - atopic. It is created by eHealthMe based on reports of 126 people who have Dermatitis - atopic from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Dermatitis - atopic?

Dermatitis - atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder) is found to be associated with 1,993 drugs and 1,973 conditions by eHealthMe. Check the latest studies of Dermatitis - atopic.

What is Nosebleed?

Nosebleed (bleeding from nose) is found to be associated with 2,080 drugs and 3,093 conditions by eHealthMe. Check the latest studies of Nosebleed.

On Jul, 13, 2026

126 people who have Dermatitis - Atopic and Nosebleed are studied.

Would you have Nosebleed when you have Dermatitis - atopic?

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Nosebleed?

- Check whether Nosebleed is associated with a drug or a condition

Related studies:

Treatments, associated drugs and conditions:

Dermatitis - atopic (61,311 reports)
Nosebleed (92,075 reports)

All the drugs that are associated with Nosebleed:

Nosebleed (2,080 drugs)

All the conditions that are associated with Nosebleed:

Nosebleed (3,093 conditions)

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Nosebleed and Dermatitis - atopic, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Dermatitis - atopic and Nosebleed

Summary:

What is Dermatitis - atopic?

What is Nosebleed?

Gender of people who have Dermatitis - atopic and experienced Nosebleed *:

Age of people who have Dermatitis - atopic and experienced Nosebleed *:

Common co-existing conditions for these people *:

Common drugs taken by these people *:

Common symptoms for these people *: